197 related articles for article (PubMed ID: 33918514)
1. The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells.
Gornowicz A; Szymanowska A; Mojzych M; Czarnomysy R; Bielawski K; Bielawska A
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918514
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-
Gornowicz A; Szymanowska A; Mojzych M; Bielawski K; Bielawska A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717981
[TBL] [Abstract][Full Text] [Related]
3. The activity of pyrazolo[4,3-
Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell lines.
Wróbel A; Kolesińska B; Frączyk J; Kamiński ZJ; Tankiewicz-Kwedlo A; Hermanowicz J; Czarnomysy R; Maliszewski D; Drozdowska D
Invest New Drugs; 2020 Aug; 38(4):990-1002. PubMed ID: 31520321
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Novel Pyrazolo[4,3-
Kciuk M; Mujwar S; Szymanowska A; Marciniak B; Bukowski K; Mojzych M; Kontek R
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682571
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolo[4,3-
Bukowski K; Marciniak B; Kciuk M; Mojzych M; Kontek R
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744887
[TBL] [Abstract][Full Text] [Related]
7. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
8. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[4,3-
Kciuk M; Marciniak B; Celik I; Zerroug E; Dubey A; Sundaraj R; Mujwar S; Bukowski K; Mojzych M; Kontek R
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446136
[TBL] [Abstract][Full Text] [Related]
10. Pyrazolo[4,3-
Bukowski K; Marciniak B; Kciuk M; Mujwar S; Mojzych M; Kontek R
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239848
[TBL] [Abstract][Full Text] [Related]
11. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.
Arun A; Patel OPS; Saini D; Yadav PP; Konwar R
Biomed Pharmacother; 2017 Sep; 93():510-521. PubMed ID: 28675857
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity of Novel Pyrazolo[4,3-
Kciuk M; Mujwar S; Marciniak B; Gielecińska A; Bukowski K; Mojzych M; Kontek R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835469
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold.
Wurz RP; Liu L; Yang K; Nishimura N; Bo Y; Pettus LH; Caenepeel S; Freeman DJ; McCarter JD; Mullady EL; Miguel TS; Wang L; Zhang N; Andrews KL; Whittington DA; Jiang J; Subramanian R; Hughes PE; Norman MH
Bioorg Med Chem Lett; 2012 Sep; 22(17):5714-20. PubMed ID: 22832322
[TBL] [Abstract][Full Text] [Related]
15. Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.
Kapral M; Wawszczyk J; Jesse K; Paul-Samojedny M; Kuśmierz D; Węglarz L
Molecules; 2017 Oct; 22(10):. PubMed ID: 28972559
[No Abstract] [Full Text] [Related]
16. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
17. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors.
Mojzych M; Ceruso M; Bielawska A; Bielawski K; Fornal E; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):3674-80. PubMed ID: 25921266
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma.
Reddy ND; Shoja MH; Jayashree BS; Nayak PG; Kumar N; Prasad VG; Pai KS; Rao CM
Chem Biol Interact; 2015 May; 233():81-94. PubMed ID: 25824412
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
20. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
Megally Abdo NY; Milad Mohareb R; Halim PA
Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
